Compile Data Set for Download or QSAR
Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 12919
LigandPNGBDBM740623(US20250154153, Compound 1218-40)
Affinity DataIC50: 0.120nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740621(US20250154153, Compound 1218-20S)
Affinity DataIC50: 0.141nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740628(US20250154153, Compound 1109-51)
Affinity DataIC50: 0.191nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740619(US20250154153, Compound 1218-39)
Affinity DataIC50: 0.191nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740622(US20250154153, Compound 1218-20R)
Affinity DataIC50: 0.209nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740620(US20250154153, Compound 1218-20)
Affinity DataIC50: 0.219nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740622(US20250154153, Compound 1218-20R)
Affinity DataIC50: 0.269nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740621(US20250154153, Compound 1218-20S)
Affinity DataIC50: 0.282nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740629(US20250154153, Compound 1109-52)
Affinity DataIC50: 0.282nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740632(US20250154153, Compound 1109-55S)
Affinity DataIC50: 0.288nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740620(US20250154153, Compound 1218-20)
Affinity DataIC50: 0.288nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740619(US20250154153, Compound 1218-39)
Affinity DataIC50: 0.398nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740627(US20250154153, Compound 1109-14)
Affinity DataIC50: 0.427nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740625(US20250154153, Compound 1218-4B)
Affinity DataIC50: 0.525nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740626(US20250154153, Compound 1109-15)
Affinity DataIC50: 0.603nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740624(US20250154153, Compound 1218-4A)
Affinity DataIC50: 0.617nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740626(US20250154153, Compound 1109-15)
Affinity DataIC50: 0.708nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740632(US20250154153, Compound 1109-55S)
Affinity DataIC50: 0.724nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740623(US20250154153, Compound 1218-40)
Affinity DataIC50: 0.794nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740630(US20250154153, Compound 1109-52S)
Affinity DataIC50: 1.07nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740628(US20250154153, Compound 1109-51)
Affinity DataIC50: 1.29nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740625(US20250154153, Compound 1218-4B)
Affinity DataIC50: 1.41nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740629(US20250154153, Compound 1109-52)
Affinity DataIC50: 1.51nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740624(US20250154153, Compound 1218-4A)
Affinity DataIC50: 1.82nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740631(US20250154153, Compound 1109-55)
Affinity DataIC50: 1.91nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (0.2 nM final concentration) w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740630(US20250154153, Compound 1109-52S)
Affinity DataIC50: 2.14nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740627(US20250154153, Compound 1109-14)
Affinity DataIC50: 2.29nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM740631(US20250154153, Compound 1109-55)
Affinity DataIC50: 5.37nMAssay Description:I. Recombinant Human Lp-PLA2 (hLp-PLA2) Enzymatic Assay Using PED6 (Invitrogen) as Substrate[0439]Recombinant hLp-PLA2 (2 nM final concentration) was...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent